Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Here’s Why Beta Bionics Filing for an IPO Is a Big Deal
Here’s Why Beta Bionics Filing for an IPO Is a Big Deal
Here’s Why Beta Bionics Filing for an IPO Is a Big Deal
Submitted by
admin
on January 23, 2025 - 11:09pm
Source:
Medical Devices and Diagnostics Industry
News Tags:
Medtech
Beta Bionics
IPOs
iLet Bionic Pancreas
Headline:
Here’s Why Beta Bionics Filing for an IPO Is a Big Deal
snippet:
Beta Bionics, the developer of the iLet Bionic Pancreas, is attempting to raise $114 million through an IPO.
Since launching the iLet in May 2023, Beta Bionics has experienced substantial growth.
Do Not Allow Advertisers to Use My Personal information
